A critical review on multifunctional smart materials 'nanographene'emerging avenue: nano-imaging and biosensor applications

K Pal, N Asthana, AA Aljabali… - Critical Reviews in …, 2022 - Taylor & Francis
Smart electronic materials 'nanographene'stated, its significant authentication has
undergone massive improvements and has emerged as a 'material of the century'in …

Emerging theranostic nanomaterials in diabetes and its complications

Y Liu, S Zeng, W Ji, H Yao, L Lin, H Cui… - Advanced …, 2022 - Wiley Online Library
Diabetes mellitus (DM) refers to a group of metabolic disorders that are characterized by
hyperglycemia. Oral subcutaneously administered antidiabetic drugs such as insulin …

A sub-10-nm, folic acid-conjugated gold nanoparticle as self-therapeutic treatment of tubulointerstitial fibrosis

CKW Chan, CC Szeto, LKC Lee… - Proceedings of the …, 2023 - National Acad Sciences
Nanomedicines for treating chronic kidney disease (CKD) are on the horizon, yet their
delivery to renal tubules where tubulointerstitial fibrosis occurs remains inefficient. We report …

[HTML][HTML] Nanomedicine tactics in cancer treatment: Challenge and hope

MS Al-Zoubi, RM Al-Zoubi - Critical Reviews in Oncology/Hematology, 2022 - Elsevier
Defeating cancer is the ultimate challenge and goal of oncologists, facing various obstacles
along with finding effective anti-cancer therapies and understanding drug delivery …

A review of the nanomaterials use for the diagnosis and therapy of salmonella typhi

R Arshad, K Pal, F Sabir, A Rahdar, M Bilal… - Journal of Molecular …, 2021 - Elsevier
The bacterial pathogen Salmonella typhi (S. typhi) causes a severe systemic disease in
humans called typhoid fever, which is a major public health issue of global importance …

[HTML][HTML] Emerging treatment strategies for diabetes mellitus and associated complications: an update

V Mishra, P Nayak, M Sharma, A Albutti, ASS Alwashmi… - Pharmaceutics, 2021 - mdpi.com
The occurrence of diabetes mellitus (DM) is increasing rapidly at an accelerating rate
worldwide. The status of diabetes has changed over the last three generations; whereas …

[HTML][HTML] Nanomedicines for the management of diabetic nephropathy: present progress and prospects

P Paul, L Chacko, TK Dua, P Chakraborty… - Frontiers in …, 2023 - frontiersin.org
Diabetic nephropathy (DN) is a serious microvascular consequence of diabetes mellitus
(DM), posing an encumbrance to public health worldwide. Control over the onset and …

[HTML][HTML] Biosynthesis of gold nanoparticles using leaf extract of Dittrichia viscosa and in vivo assessment of its anti-diabetic efficacy

S Ayyoub, B Al-Trad, AAA Aljabali, W Alshaer… - Drug Delivery and …, 2022 - Springer
Several studies have reported the anti-diabetic effect of biologically synthesized gold
nanoparticles (AuNPs). This study was designed to investigate the in vivo anti-diabetic …

[HTML][HTML] Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer

R Raguraman, A Srivastava, A Munshi… - Advanced drug delivery …, 2021 - Elsevier
Diabetes mellitus (DM), is the most common metabolic disease and is characterized by
sustained hyperglycemia. Accumulating evidences supports a strong association between …

[HTML][HTML] Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives

HQ Zhan, X Zhang, XL Chen, L Cheng… - Journal of …, 2024 - Springer
Glomerulonephritis (GN) is the most common cause of end-stage renal failure worldwide; in
most cases, it cannot be cured and can only delay the progression of the disease. At …